A Study of Recombinant Vaccinia Virus Prior to Sorafenib to Treat Unresectable Primary Hepatocellular Carcinoma

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2011 by Jennerex Biotherapeutics.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by (Responsible Party):
Jennerex Biotherapeutics
ClinicalTrials.gov Identifier:
NCT01171651
First received: July 26, 2010
Last updated: January 13, 2014
Last verified: June 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: June 2014
  Primary Completion Date: February 2013 (Final data collection date for primary outcome measure)
No publications provided by Jennerex Biotherapeutics

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):